.
2.
2.
6
.
6
6
©
©
©
©
©
©
©
0
©
ew
© ©
we
©
we
©
tw
ew ow
lw
we
tlt lw
eh tll
tl
tl
...
2 2 2
+
6
6
©
«©
«©
©
©
©
©
©
©
©
we
©
we
©
ew
we
tw
we
we
we ow
ee we
we
tht
...
2.
2
«
©
©
©
©
©
©
we
ee
2.
Residual Radiation . . 1.
Data Evaluation
.....-.
1
«©
1
«©
0
©
ee
© ©
ew
©
we
©
we we
ow
+.
6
«©
©
«©
©
«©
©
©
ee
ee
oe
©
we
we
ew we
oe
we
we
et
te
ACKNOWLEDGMENTS
INTRODUCTION . 2.
IV.
E.
GENERAL MEDICAL SURVEYS
....
we
we
ee
te
ew
ew
we
we
we
we
we ww
ee
©
©
@
©
ww
A.
Background . 2. 2 2 1 we ee ww we we we he
Methods
. . 2. «©
1.
Procedures .
«©
2.
©
2.
©
2
e
6
© © ©
«6 ©
C.
Results
«
6
©
«©
«©
©
©
©
©
©
ow
ew
ew
ww
ht
we
wl
..
.
2.
6
«©
©
«©
©
©
©
©
©
we
wh
we
Methods
.. 2. 6 «© «© e «©
Results and Discussion .
©
.
©
1.
©
2.
©
6
ee
ss
we eh
eo
ee
we
tt htt
we ew we we
wh
ww
2.
2.
©
«©
«©
©
©
©
©
©
ww
© © we
© © © ©
«es
eo
we
.
we
ew
we
we
.
eo
ew
ew we ow ew te we
we we we tt wt
Pe
2.
Control Populations
.
.
2.
6
HEMATOLOGIC OBSERVATIONS
A.
B.
C.
B.
C.
eh eh we ht
tht
tw
tt
tlt
........ 6 © «© © we we be wo
©
©
Background . . 6 6 6 6 ee ee we ew we we ww tt het
GROWTH AND DEVELOPMENT
A.
A.
.
..
©
©
©
ew
wo
Background . . . 1. 6 2 2 6 2 © ee we we we we ew we he tee
Methods
... 2. 6 © ©
Results
. . 2... 6» «©
Discussion. ....s+s
IMMUNOLOGICAL,
Aging Studies
..
©
©
+
CHROMOSOME, AND GENETIC STUDIES
1.
1
6
ee
ee
we
ee
ew
ee
we
we
ew
tw wl
ry
....
th
th
»
es
Immunological Studies .... 2. 1 2 es eee eee wees
Chromosome and Genetic Studies . .... 2 © «© © pe © ewe
1. Chromosome Studies . . 1... 2 2 es © se ee we we we we wwe
2. Isoleucine Misincorporation in Hemoglobin A of Marshallese
3.
Detection of Mutant Proteins ....+.+«.« «ees
.
PARASITOLOGIC SURVEYS AND SUPPRESSIVE ANTI-HELMINTH TREATMENT oN
RONGELAP AND UTIRIK, 1977-1979 . 2. 2 2 6 0 1 ee ww we ww we
A.
B.
IX.
ee ee
el th
Early Clinical Effects . . 2. 2. 6 2 2 2 we ee ew we ee we
Dosimetric Evaluation . .. 1 2. 2 es se se tw ee we wens
1, Early Radiation . . 1. 26 © «6 6 ww we © ew we we tw ww
The Accident .
AGING,
VII.
VIII.
wh
lh
ltl lll
tll
C.
D.
B.
C.
D.
VI.
lt lt
tll
Background... 1.6 6 ee ee bee ee eee he te
B.
IIl.
«©
«©
A.
B.
Il.
2
«©
C.
D.
Background . 2. 2 se 6 eo ee eo ew we eo we we wt ww tt et
Methods
...
2.
2.
2
es
ee
©
wo
oe
oe
eo
ww
www
ww
Results and Discussion . .. 2... 6 + se ee ee we wwe
Conclusions .. 2... 5 se ee ee we ew wwe ww ee ewe
DIABETES SURVEY
. . . 2
NEOPLASIA (NON-THYROID)
6 6 2
...
©
2.
«©
es
©
+
@ ©
ee
wo ew
we ee
hw
ee
eh we we he
eevee veas
THYROID ABNORMALITIES
2.
6
©
©
©
8s
eo
we
A.
B.
C.
A.
Malignancies . 2... 2. 2 eee we eo eee eee eee eevee
Benign Tumors . . 2. 6 6 6 ee ee we ee we ew we we we ww es
Pituitary Tumor .. 1... 6 ee we ee we et te we he
.
2.
6
©
Background (Chronology of Developments)
xii -
©
©
wh
ew
wo
we
.....+.-+e«e.
OMmMnNUOW WN RK
DEDICATION
PREFACE
.
=
he
Rs
CONTENTS